CRWV ends the week with a familiar tension intact — shorts have built a material position, options traders are more defensive than they have been all year, and yet the analyst consensus remains firmly constructive.
Short interest has continued its steady climb. At 17.2% of the free float, the position is up roughly 9% on the week and 10% over the past month — a persistent build that has now run through both the June rally and the subsequent reversal. Since the June 9 note flagged shorts adding into a 19% bounce, they have added a further 6.5 million shares and shown no sign of covering. The borrow market offers no friction to new entrants: availability is at 428%, meaning roughly four shares remain available for every one already borrowed, and cost to borrow is just 0.46% — essentially free. What changed from yesterday's convergence note is that SI ticked back slightly, down 3.8% on Tuesday from Monday's peak of 69.2 million shares. The direction of travel remains higher, but the pace appears to have paused.
Options positioning tells the more urgent story right now. The put/call ratio hit 0.92 on Tuesday — more than three standard deviations above its 20-day mean of 0.78. That is the most defensive options reading CRWV has seen outside of its 52-week high of 1.70, and it has jumped sharply from 0.75 just a week ago. The stock is down 9.7% on the week to $105.72, so some of that put demand reflects hedging of existing long positions after the sell-off rather than fresh bearish conviction. Still, the gap between current PCR levels and the recent baseline is notable — the z-score of 3.4 is the highest observed over the tracked period.
The Street remains largely unconvinced by the bearish case. The analyst consensus is a buy, with a mean price target of around $140 — representing roughly 32% upside from current levels. The most recent coverage activity, from Cantor Fitzgerald in mid-June, reiterated an Overweight rating with a $167 target. BNP Paribas initiated at Outperform with a $192 target on June 2. The outlier is DA Davidson, which downgraded to Neutral in May with a $100 target — essentially spot price — citing debt levels and moderate margin trajectory. JP Morgan sits at Neutral with a $105 target, also close to current trading. Bulls point to strong backlog growth, concentrated AI infrastructure demand, and major hyperscaler relationships. Bears highlight a capital-intensive build-out, negative free cash flow, and competition from established cloud providers. The ORTEX analyst recommendation divergence factor scores at the 98th percentile, signalling an unusually wide spread between optimists and pessimists on the Street.
Magnetar Financial, listed as a 10% holder, disclosed multiple sell transactions on June 22 totalling roughly $7.4 million at prices around $117.95. These came as the stock was already selling off. Magnetar still holds approximately 53 million shares per last reported data, so the disclosed sales represent a small reduction rather than an exit — but the timing, at the top of a range that has since broken lower, is worth noting.
Earnings history adds another layer. The May 7 print triggered a 17% next-day decline with losses extending to the same level over five days. The June 8 event produced a much smaller initial drop of 1.9%, followed by a 6.3% recovery over five days. The next scheduled earnings date is August 6. Between now and then, the key question is whether the current short-interest build — persistent through both a rally and a reversal — reflects genuine fundamental concern or positioning that has become crowded enough to create its own risk on any positive catalyst.
See the live data behind this article on ORTEX.
Open CRWV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
